Susquehanna International Group, LLP Lyra Therapeutics, Inc. Transaction History
Susquehanna International Group, LLP
- $568 Billion
- Q1 2024
A detailed history of Susquehanna International Group, LLP transactions in Lyra Therapeutics, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 343,322 shares of LYRA stock, worth $96,130. This represents 0.0% of its overall portfolio holdings.
Number of Shares
343,322
Previous 259,416
32.34%
Holding current value
$96,130
Previous $1.36 Million
57.1%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding LYRA
# of Institutions
82Shares Held
44.4MCall Options Held
300KPut Options Held
1.3K-
Perceptive Advisors LLC New York, NY12.8MShares$3.57 Million1.67% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il4.34MShares$1.21 Million0.01% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT2.82MShares$789,8741.13% of portfolio
-
Samsara Bio Capital, LLC Palo Alto, CA2.78MShares$778,4735.45% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct2.74MShares$767,8880.04% of portfolio
About Lyra Therapeutics, Inc.
- Ticker LYRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 31,826,400
- Market Cap $8.91M
- Description
- Lyra Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained...